NasdaqGS - Nasdaq Real Time Price USD
Taysha Gene Therapies, Inc. (TSHA)
1.8350
+0.0150
+(0.82%)
As of 11:03:29 AM EDT. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 37.58M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| NOLAN SEAN PATRICK Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 2, 2025 |
| NAGENDRAN SUKUMAR President | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 2, 2025 |
| ALAM KAMRAN CPA Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 2, 2025 |
| MANNING PAUL B. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 2.25 per share. | Direct | 2,999,999 | Jun 27, 2024 |
| DONENBERG PHILLIP BRIAN Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 29, 2024 |
| STALFORT JOHN A III Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 29, 2024 |
| SEPP-LORENZINO LAURA Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 29, 2024 |
| LONG ALISON S Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 29, 2024 |
| NOLAN SEAN PATRICK Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 2, 2024 |
| NAGENDRAN SUKUMAR President | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 2, 2024 |
| ALAM KAMRAN CPA Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 2, 2024 |
| MANNING PAUL B. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 1.63 per share. | Indirect | 163,000 | Nov 17, 2023 |
| ALAM KAMRAN CPA Chief Financial Officer | Sale at price 2.33 per share. | Direct | 76,890 | Aug 24, 2023 |
| DONENBERG PHILLIP BRIAN Director | Purchase at price 2.18 per share. | Direct | 242,222 | Aug 16, 2023 |
| MANNING PAUL B. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 2.18 per share. | Indirect | 35,897,334 | Aug 16, 2023 |
| NOLAN SEAN PATRICK Chief Executive Officer | Purchase at price 2.18 per share. | Indirect | 968,888 | Aug 16, 2023 |
| STALFORT JOHN A III Director | Purchase at price 2.18 per share. | Indirect | 1,695,556 | Aug 16, 2023 |
| SESSION R. A. II Beneficial Owner of more than 10% of a Class of Security | Sale at price 0.70 - 0.71 per share. | Direct | 60,771 | Jul 13, 2023 |
| SESSION R. A. II Beneficial Owner of more than 10% of a Class of Security | Sale at price 0.70 per share. | Direct | 20,119 | Jun 23, 2023 |
| SESSION R. A. II Beneficial Owner of more than 10% of a Class of Security | Sale at price 0.70 - 0.71 per share. | Direct | 307,844 | Jun 21, 2023 |
| ALAM KAMRAN CPA Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 31, 2023 |
| NAGENDRAN SUKUMAR President | Purchase at price 0.68 per share. | Direct | 3,400 | May 16, 2023 |
Related Tickers
FDMT 4D Molecular Therapeutics, Inc.
3.3400
-2.34%
NGNE Neurogene Inc.
15.44
0.00%
LXEO Lexeo Therapeutics, Inc.
3.3725
+0.07%
TNYA Tenaya Therapeutics, Inc.
0.4521
+0.13%
SLDB Solid Biosciences Inc.
3.5900
+0.84%
RCKT Rocket Pharmaceuticals, Inc.
7.34
+2.80%
RZLT Rezolute, Inc.
4.0100
+1.01%
CCCC C4 Therapeutics, Inc.
1.5650
-2.80%
VERV Verve Therapeutics, Inc.
5.69
+4.02%
QURE uniQure N.V.
14.64
+1.74%